packageAbetimus

abetimus

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Abetimus is an investigational immunosuppressant that was developed for the treatment of lupus nephritis. It was never marketed; a marketing application in the European Union was withdrawn, so it remains an investigational drug.

Summary written by glm-5.3-flash from Wikidata Q4667244 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:abetimus
ATC codes:L04AA22
DrugBank:DB06662
Wikidata:Q4667244

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown